Drug Discovery

(Image: Getty/kunertus)

Charles River signs on to Dementia Consortium

By Melissa Fassbender

Charles River Laboratories recently announced that Alzheimer’s Research UK selected the company to join the Dementia Consortium to help researchers progress projects to in vivo proof of concept.

(Image:Getty/ADragan)

Outsourced drug discovery market to top $68bn in 2028

By Maggie Lynch

The global drug discovery market is expected to reach $68bn in 2028, according to a Visiongain report, with revenue gains driven by flexibility, agility, and the ability to innovate, says Evotec executive.

(Image: Getty/daizuoxin)

Gilead taps HitGen for drug discovery

By Melissa Fassbender

Gilead and HitGen have signed a drug discovery collaboration – one of several recently announced agreements as HitGen sees increased demand for its technology, says CSO.

(Image: Getty/f11photo)

Yale taps Genesis CRO for drug discovery services

By Maggie Lynch

Yale University is partnering with CROs to provide drug discovery services to awardees of the Blavatnik Fund for Innovation – which aims to bridge the gap between early-stage research and product development.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All